Try our Advanced Search for more refined results
Life Sciences - March, 2017
373 articles
- Kimberly-Clark Gowns Failed Quality Tests, Jury Told
- Key Patents Wiped Out For Acorda's Flagship MS Drug
- A Law Firm's Guide To Social Media
- Tyco, Mutual Settle Long-Running Restoril Patent Suit
- Hedge Fund Drug Patent Challenges In Doubt After Bass' Test
- Dicerna Selling $70M In Preferred Stock To PE Group
- Health, Pharma Sectors Will Be FTC Focus, Ohlhausen Says
- Ex-Philly US Atty Predicts No Falloff In FCA Enforcement
- A Sign Of Targeted Patent Reform In Congress?
- Kimberly-Clark Exec Defends 'Quality Issues' In Fraud Trial
- Online Casanova Agrees To Pay $1.8M SEC Penalty
- Pharma Cos. Made $1B Off Wasted Cancer Drug, Suit Says
- FedEx, Merck, Quest Hit With Patent Suits Over QR Codes
- IP Licensing Co. Must Pay Medtronic's Fees In Stryker Case
- Witness's Medical Aid To Juror Spurs Pa. Risperdal Mistrial
- GSK Asks 3rd Circ. To Ignore Prior Ruling In Wellbutrin Case
- Valid Claim Buoys $131M Hearing Aid IP Verdict, Court Told
- Device Maker Wins Toss Of Investors' Illegal Kickback Claims
- Ohio Surgery Center Escapes Patients' FCA Suit
- Boehringer Ruling Limits Treatment Method Patent Eligibility
- The Future Of Off-Label Promotion And Product Liability
- Kimberly-Clark's Cost-Cutting Caused Gown Issues, Jury Told
- FDA Rejects Mylan's Application For Generic Advair
- Gov't Can't Duck Medicare Contract Cancellation Suits
- FTC May Turn Away From Court For Complex Conduct Suits
- FTC Tells DC Circ. To Undo Boehringer Doc Privilege Ruling
- Feds Win Extra Event Docs In Novartis Kickbacks Suit
- GenVec Shareholders Sue Over Intrexon Merger
- Rosen Law Firm Evades Sanctions For Quick Cellceutix Suit
- Delrahim: The Right Captain For The Antitrust Division
- Monsanto Denied Pause Of Doc Handover In Syngenta MDL
- PE Firms Collect $1.2B In Sale Of ConvaTec Shares
- Allergan Gets Patent Claims In Botox Suit Nixed At PTAB
- 'Frontier' Issues: Pay-For-Delay And Patent Holdup
- English High Court And Narrowing Scope Of Legal Privilege
- Pleading Civil RICO: Lessons From The Abbott Litigation
- EU Endocrine Disruptor Fights Could Lead To US Litigation
- A Startup Attorney's Tips To Advance Company Diversity
- UC, Medivation Argue Old Fights Decide Drug Royalty Row
- Novartis Gets Partial Win In Transplant-Drug Patent Dispute
- 3rd Circ. Won't Send Birth Control Mass Tort To State Court
- Clovis Investor Sues In Chancery Over Cancer Drug Trials
- Judge Frustrated At Sluggish Pace Of Atty Suicide Trial
- Trial Date Set For 2nd Meningitis Defendant
- FDA Warning Wire: Stem Cell Study, Bad OTC Promos
- Bayer Sues Apotex Over Cancer Treatment Patent
- Vitamin Maker Must Face 'Made In USA' Class Action
- Ex-Katten Atty Says Indictment In Shkreli Case Is 'Careless'
- What New Bulk Substance Rules Mean For The Drug Industry
- Pfizer, Ex-Employee Reach Agreement In Trade Secrets Row
- Rite Aid Wants Out Of FCA Suit Claiming Decadelong Scheme
- Goodwin Nabs Ex-Lando & Anastasi IP Atty For Boston Office
- Fosamax Ruling Aids Wellbutrin Case, 3rd Circ. Told
- Judge Gorsuch's Dubious Commitment To Legal Textualism
- SEC Scrutiny Of Non-GAAP Disclosures Likely To Continue
- Ex-Valeant CEO Sues Drugmaker Over Alleged Unpaid Shares
- Atty's Doc Says He Didn't Know Of Paxil's Suicide Risk
- Berkeley Team Gets European CRISPR Win After PTAB Loss
- ClearCorrect Gets PTAB To Nix Claims Of Invisalign Patent
- Ionis Subsidiary Akcea Files $100M IPO Led By Cooley
- Spurned Implant Inventor Again Beats PTAB At Fed. Circ.
- Salix To Pay $210M To Settle Stock Inflation Class Action
- Are Your In-House Lawyers Happy?
- Polsinelli Adds Ex-Foley & Lardner IP Atty As Shareholder
- FTC Gets Ex-Patent Atty Testimony Blocked In Androgel Suit
- Alcon Sues Lupin Over Itchy-Eye Solution Generic
- Trump's Proposed 2018 Budget Will Double FDA User Fees
- Justices Send Patent Laches Appeals Back To Fed. Circ.
- Stryker Loses Bid To Keep Poaching Suit Against DJO In NJ
- Sperm Bank Can't Dodge Couple's Suit Over Donor Portrayal
- Sullivan Worcester Reps SNH On $261M Property Stake Sale
- Proposed Rules Pose Challenges For Pharma Reps In Chicago
- Post-Escobar Courts Reaching Consensus On FCA Materiality
- Health Hires: Tucker Ellis, Wilkinson Walsh
- Medtronic Urges High Court To Open PTAB Up To More Review
- ABA President Balks At Rep's Call For More Lawyer Ad Regs
- Stryker Unit Fights To Keep DJO Poaching Suit In NJ
- Janssen Beats Untimely Calif. Appeal Over Risperdal Death
- 2 Express Scripts Claims Tossed In Anthem Contract Dispute
- Ex-Monsanto Lawyer Must Hand Over Docs In Syngenta MDL
- Fraud Claims Must Be Pulled After Smears In Pharma Co. Row
- Understanding Defense Strategies For 505(b)(2) Drugs
- 3 Sentenced In Fla. For $175M Health Care Fraud Scheme
- Pa. Judge Tosses Actiq Off-Label Marketing Suit
- TC Heartland May Cause Protective Suits In ANDA Cases
- Google, NASA, Planes And A Stronger Legal Team
- Verdict Form Reveals Close Call In Meningitis Murder Case
- Eli Lilly Case Leaves Big Questions For Another Day
- Ex-InterMune Exec Lied During SEC Trial, Judge Says
- PTAB Upholds Vimpat Patent In Generic Makers' Challenge
- CORRECTED: Diabetes Company Valeritas Prices $54M Offering
- Trial In Biomedical Stock Scheme Delayed
- Fed. Circ. OKs Rejection Of $8M Fee Bid In Gene Patent Case
- Bernstein Litowitz Gets Lead Counsel In Del. InSys Suit
- Supplement Co. Lied About Biotin Benefits, Class Action Says
- SEC Nets Insider Trading Settlement Over Merck Deal
- Generics Face Antitrust Suit Over Antidepressant Prices
- FINRA, DTC Accused Of Sending $8M To Wrong Investors
- Medical Device Giant Medtronics Sells Bonds Totaling $2B
- NuVasive Investors Win Cert. In Kickback Class Action
- Reducing Administrative Burden Under New 'Common Rule'
- Expectations For High Court Patent Exhaustion Decision
- 10 Tips For Better Legal Negotiations
- 11th Circ. Affirms $2.1M Verdict In Wright Hip Implants Suit
- 9th Circ. Buoys Policyholders In Excess Settlement Fights
- Fla. Senators Delve Into Medical Marijuana Rules Proposals
- Lilly, Biz Groups Rip Tribunal's Decision On 'Promise Doctrine'
- UK Judge Nixes Patent Extension For Merck HIV Drug
- Pharma Slams Wash. City's Suit Over Illegal OxyContin Sales
- Ex-MLBer Says Notes Show 'Sloppy' Insider Trading Probe
- Intelligender Hit With Penalty In Calif. False Ad Suit
- Drug Cos. Fight Bid For Quick Win In Namenda Antitrust Suit
- Abbott Denied Early Win In GSK Suit Over HIV Drug Cost
- Diag Human Says $325M Award Was Never Nullified
- 4 Firms Lead Canadian Biotech Aurinia's $173M Follow-On
- Breast Implants Linked To Rare Cancer, 9 Deaths, FDA Says
- Ex-Pot Dispenser Exec Pays SEC $12M Over Fraudulent Sales
- Why Patient Experience Data Provisions Face Elimination
- 3rd Circ. Revives Fosamax Warning Class Against Merck
- Damages Nixed In Generic Blood-Clot Drug Monopoly Suit
- Fund Sues For Biotech Royalty Biz Books To Aid Proxy Fight
- Jury Convicts Drug Return Co., CEO In $116M Fraud Case
- Arrowhead Investors Ask 9th Circ. To Restore Drug Trial Suit
- Plaintiffs Bar Perspective: Beasley Allen's Dee Miles
- Gray Matters: Decision Error
- Pharmacist Convicted Of Racketeering, Cleared Of Murder
- FDA Warning Wire: Data Woes For Foreign Drugmakers
- Sanofi Sues Amgen To Protect Eczema Drug From IP Claims
- FDA Expert Says GSK In Charge Of Paxil Label Changes
- AIG Unit Must Cover $3.75M Ad Injury Claims, 9th Circ. Says
- Spain Probes Pharma Giants For Restricting Competition
- PTAB Upholds Biogen Drug Patent In Hedge Fund Challenge
- Deals Rumor Mill: SoftBank, PPG, Dominion Diamond
- Levi Korsinsky Seeks Lead Role In Birth Control Investor Suit
- Law Schools And Law Firms: Seeking Common Ground
- The Rate Of PGR Petitions Hitting Orange Book Patents
- D&O Insurance And The Conduct Exclusion
- Boiron Buyers Say Jury's False Ad Verdict OK'd Sugar Pills
- Pa. Jurors Ready To Mull $116M Drug Refund Fraud Case
- Walgreens Wants Out of Theranos Blood-Testing Suit
- Trump's HHS Moving Fast To Grant Industry Wishes
- Uphold Express Scripts Quick Win Denial, Pharmacies Urge
- GSK Can't Nix Expert Testimony In Atty Suicide Trial
- Feds Indict Fugitive CEO, CFO For $426M Securities Scheme
- Meningitis Murder Trial Judge Homes In On Intent To Defraud
- FDA Probing Abbott Device's Higher Rate Of Cardiac Events
- Clovis Oncology Stock-Drop Claims Still Fall Short, Court Told
- Plaintiffs Bar Perspective: Motley Rice's Linda Singer
- Justices Reject Bid To Revive $340M Becton Antitrust Verdict
- Why We Need The Fairness In Class Action Litigation Act
- Fed. Circ. May Be Setting Stage For Big Obviousness Changes
- Regulatory Pathways Emerge For Gene-Edited Products
- Killing Class Actions Means Everybody Loses
- Not From Around Here? Trying A Case As An Out-Of-Towner
- Canada Prevails In $383M Eli Lilly Case
- Fed. Circ. Backs Dow's $5.9M Fee Award In Bayer Patent Case
- Bostwick Ch. 11 Thrown Into Crisis By Medicare Funds Freeze
- Pain Drug Co. Insys Faces Stock-Drop Suit After Audit News
- FDA Delays Off-Label Rule Opposed By Big Pharma
- Sheller Urges Justices To OK Standing In FDA Risperdal Row
- FTC, Spam Marketers Settle Charges In Fake Diet Pill Case
- Allergan Defends 3-Month Exclusivity Deal For Namenda
- Fed. Circ. Upholds Ax Of Latisse Patent Suit Against Sandoz
- FTC Can't Dodge Ruling On Litigation Authority, Watson Says
- Jury Grapples With Murder Charges In Meningitis Outbreak
- IMS Health Settles Antitrust Coverage Suit With Zurich
- 9th Circ. Affirms Amgen Win In Late Off-Label Sales Row
- German Drug Co. Stada Rejects 2 PE Takeover Offers
- Costco Shoppers Score Cert. In Supplement Labeling Suit
- Galena Lied About Illegal Fentanyl Marketing, Investor Says
- GNC, Consumers Agree To End 'Slack Fill' Suit
- 2 Noerr-Pennington Rulings Affirm Narrow Scope Of Immunity
- Trump's Hiking Of FDA User Fees Unlikely To Speed Approvals
- Another Bellwether Drops Out Of Zimmer Knee Implant MDL
- Roche, Pharmacies Reach $17M Deal Over Unwanted Faxes
- Pa. Jury Urged To Reject $116M Drug Refund Fraud Charges
- Kan. Chemist Charged With Illegally Storing Hazardous Waste
- Warner Chilcott Wins Discovery In Loestrin Pay-For-Delay MDL
- Myomo Seeks To Be 1st Reg A+ Co. To List On NYSE Venue
- 'Greed And Fraud' At Deadly Pharmacy, Murder Trial Jury Told
- Cephalon Settles FCA Suit Over Provigil Marketing
- Contract Confusion Can't Sink Drug Patent Row, Judge Says
- AstraZeneca, Zydus Reach Deal To End Nexium IP Suit
- Medtronic Investor Wants Full 8th Circ. To Rethink Case
- When The JPML Refuses To Approve Multidistrict Litigation
- What PTAB Markush Rejection Means For Biotech Applicants
- Dow Hits Teva, Actavis With Suit Over Generic Acne Med
- Allergan Investors Win Cert. In Valeant Insider Trading Row
- FDA Rejected Paxil Label Changes, GSK Says In Suicide Trial
- 2nd Xencor Class Deal Seeks $2.4M To End Recap Fight
- Ex-Oppenheimer Adviser Gets 6 Months For Insider Trading
- Greenberg Traurig Atty Brings Deep Resume To HHS Post
- FDA Panel Says Endo Painkiller Risks Exceed Benefits
- Union Hits Mylan With 2 Generic Drug Price-Fixing Suits
- There's More On USTR's Plate Than New Tariffs And NAFTA
- Puma Biotech Investors Seek Class Cert. In Stock-Drop Case
- 'Presumption Of Validity' Barred From Cialis Patent Trial
- 'Incoherent' Args Can't Defeat Roca Asset Freeze, FTC Says
- High Court Urged To Reverse Calif. Justices' Plavix Ruling
- J&J Wants Pa. Mesh Cases Paused For Jurisdiction Appeal
- Gilead Beats $50M Drug Bonus Call In Del. Chancery Ruling
- Declining Reimbursements Send Cancer Testing Co. To Ch. 11
- Blackstone Sells Life Sciences, Medical Campus For $130M
- Ex-Hunton Patent Atty Convicted Of Insider Trading
- Calif. Diabetics Denied Refund On Test Strip Sales Tax
- Biotech Co. Sued Over Stock Drop After Bad Clinical News
- A Dive Into BPCIA Confidential Info Disclosure Requirements
- FDA Faces Uncertainty Implementing 21st Century Cures Act
- Jefferies Seeks End To FINRA Arbitration Over Biotech Stock
- Medical Device Maker Seeks To Kill Weight Loss System Suit
- GSK Owes $12M To Widow of Reed Smith Atty, Jury Hears
- Mylan, Genentech Strike Deal For Herceptin Biosimilar
- Nonprofit Rips IRS' Teva Summons In Donation-Benefit Probe
- Multivitamin Has Dangerous Folate Levels, Suit Says
- Deals Rumor Mill: Walgreens, Neiman Marcus, Sealed Air
- FDA Warning Wire: Scofflaw Shuttered After 5-Year Saga
- Experts Ordered To Produce Medical Records In Benicar MDL
- 10th Circ. Affirms Suture Co. Loss In $200M Antitrust Suit
- FTC Fights Impax Bid For Fees In Pay-For-Delay Case
- Valeant Libido Drug Sales Claims Cut In Half
- Shareholder Wants Freeze On Allergan's CoolSculpting Deal
- Class Certified In 'Natural' Baby Wash Case Against J&J
- Ackman Sells Entire Valeant Stake, Takes Huge Loss
- How The Most Profitable Law Firms Structure Their C-Suites
- Veeva Countersuit Alleges IMS Monopoly Over Data Products
- Ex-Hunton Atty's Tip Not Enough To Trade On, Jury Told
- FDA Panel Weighs Safety Issues Of Endo Opioid Painkiller
- Pharma Cos. Seek To Toss Blood Pressure Drug Antitrust Suit
- Carnegie Mellon Turns To Fed. Circ. To Save Implant Patent
- W. Va. County Says Walgreens, Others Fed Opioid Epidemic
- Generic Skin Cream Buyers Fight Price-Fixing Row Dismissal
- Senate Approves Trump's CMS Administrator Pick
- Judge Skeptical Of FDA Fraud In Meningitis Murder Trial
- Sony Escapes Suit Over Dr. Oz's 'Miracle' Diet Pill Promos
- Keeping Ethics Paramount In The Direct Selling Industry
- Settlement Strategy: What Does The Client Really Want?
- Bharara Fired After Refusing To Resign
- Texas Justices Steer Clear Of Spat Among Fen-Phen Lawyers
- Amgen Warns Of 'Chaos' In High Court Biosimilar Clash
- End-Payor Actions Consolidated In Propranolol Antitrust Row
- 5 Fast Facts About Trump's Pick For FDA Chief
- PTAB Invalidates Claims In Hip Implant Patent
- Acorda MS Drug Patents Survive Kyle Bass PTAB Challenges
- Struggling Valeant Raises $3.25B In Bonds To Revamp Debt
- AbbVie Must Face Investors' Suit Over Failed $55B Merger
- Health Hires: Polsinelli, Pepper Hamilton, Mintz Levin
- Sessions Asks Obama's 46 Remaining US Attys To Resign
- 9th Circ. Says Rules Don't Call For Asbestos Suit's Eternal Nix
- Gorsuch's Views On 'Legal Tourism' Could Shift High Court
- In The Associate Lateral Market, All Law Firms Are Not Equal
- Whistleblower Protections Vs. Confidentiality Obligations
- GSK, Reed Smith Partner's Widow Preview Paxil Jury Trial
- Ex-Hunton Lawyer In Tears As Judge Refuses To Nix Charges
- Judge Gives Initial OK To Direct Digital $4.5M False Ad Deal
- Fed. Circ. Won't Look At Reach Of AIA Estoppel Provision
- 9th Circ. Urged To Recertify 'Sexual Energy' False Ad Class
- Immunomedics Transaction Halted By VenBio Challenge
- Drug, Device Makers Urge New Kickback Safe Harbors
- Reflections From A Mock Trial
- Estate Planning For The Cannabis Client
- Atty Convicted In NFLer's Stock Scheme Wins Coverage
- Perkins Coie Lures IP Partner From WilmerHale In LA
- Law Prof's Testimony Tossed In $116M Drug Return Co. Suit
- Deals Rumor Mill: Bayer, Novomatic, Stada
- Drug, Pharma Benefit Cos. Sued Over Insulin Pricing
- Prosecution Rests In Meningitis Murder Trial
- Truck Stop Asks 3rd Circ. To End $9M Drug Theft Dispute
- 6 Legal And Regulatory Risks Facing Specialty Pharmacies
- Ex-Broker Tells Of Cover-Up Over Ex-Hunton Atty's Inside Tip
- Stryker Says Biomet Poached Sales Reps, Customers, Secrets
- Durham Jones Nabs Ex-Snow Christensen IP Attys
- Drug Cos., Eye Drop Users Spar Over 7th Circ. Toss
- Pharma Co. Hit With Investor Suit Over Freeze Of Drug Study
- Deals Rumor Mill: PPG Industries, Toshiba, Novo Nordisk
- Lilly Denied Quick Win On Willful Infringement Under Halo
- Pharmacist Faked Docs After Eye Surgery Mishaps, Jury Told
- FTC Looks To Bar Ex-Patent Atty's Testimony In Androgel Suit
- Bard Stent Grafts Don't Infringe Gore Patents, Jury Finds
- NantHealth Sued After News Report Leads To Stock Drop
- Roche Wants Russian Co., Counsel Penalized For Drug Suit
- Plaintiffs Bar Perspective: Lieff Cabraser's Lexi Hazam
- District Courts And PTAB Are Divided On IPR Estoppel
- NJ Consumers Urge Court To Revive Accutane Litigation
- Ex-BigLaw Atty's Pfizer Tip Shared Among Friends, Jury Told
- Zimmer Dismissed From 137 Suits In Knee Implant MDL
- GSK Wants Paxil Study Testimony Nixed In Suicide Case
- Amgen Sues Coherus Over Chemo Drug Trade Secrets
- FDA Warning Wire: Wockhardt Again In FDA Crosshairs
- Ranbaxy Ex-Owners Must Hand Over Asset Info In Award Row
- Shining A Light On GOP Plan For Health Care Reform
- Shkreli, Ex-Katten Atty Should Not Split Trial, Feds Say
- Beyond Pay-For-Delay: 3 Pharma Antitrust Cases To Watch
- Feds, Drug Return Co. Spar Over Law Professor's Testimony
- Cannabis Industry Standards: ASTM May Fill The Vacuum
- Momenta Isn't Shielded From Antitrust Suit, 1st Circ. Says
- 7th Circ. Nixes Glaucoma Eyedropper Class Claims
- Judge OKs $12M Caldera Pelvic Mesh Deal Amid Protests
- UK Judge Nixes AbbVie Humira Patents In Biosimilars Case
- Immunomedics Directors File New Suit In Heated Proxy War
- Ex-BigLaw Partner Tells Jury He Wouldn't Break Law For $15K
- Depakote Trial Shelved Because Of Expert Witness's Illness
- Akorn Must Face Claims In VersaPharm Integration Suit
- Supplement Co. Hid SEC Subpoena, Investors Say
- PTAB Rejects IPR Challenge To Genentech Arthritis Patent
- Pharmacist Broke Down In Tears After Patient Died, Jury Hears
- PTAB Upholds Juxtapid Patents In Hedge Fund Challenge
- Pharmacy Targets Heritage, Mylan, Others Over Drug Prices
- Pa. Sen. Floats 'Right To Try' Legislation
- Direct Digital To Pay $4.5M In False Ad Settlement
- Data Analytics Now Cost-Effective For Smaller Firms
- Consumers Seek Certification In Contact Lens Antitrust MDL
- No Preemption Split To Resolve In Reglan Case, Justices Told
- Smear-And-Short Defendant Looks To Ax Default Judgment
- 'Oh, No,' Pharmacy Chief Said As Meningitis Crisis Widened
- Judge Hands Win To J&J In Latest Philly Risperdal Case
- High Court Asked To Clarify Biz Speech Antitrust Liability
- Judge Lays Out BPCIA 'Patent Dance' Rules
- J&J Gets Its First Win In Mo. Talcum Powder Trials
- GSK Won't Produce Docs In Merck Antitrust Suit, Buyers Say
- Geron, Investors Reach $6.25M Settlement In Cancer Drug Suit
- UK Accuses Actavis Of Inking Deals To Prop Up Drug Prices
- Don't Underestimate The Value Of An Internal Audit
- Fresenius Wins Bellwether Trial Over Dialysis Treatment
- Biosimilar Rules Likely To Survive ACA Battle, Lawyers Say
- In Talc Closings, J&J Invokes Dred Scott
- Goodwin Procter Partner Joins Cooley's Life Sciences Team
- Concordia Pharma Gets False Ad Trial Award Upped To $2.2M
- Mudslinging After BioZone Settlement Stumps Judge
- Celexa, Lexapro Buyers Want Class Cert. In Marketing MDL
- Cancer Treatment Center Hits Ch. 11 With $180M In Debt
- US, EU Reach Deal To Use Each Other's Drug Inspections
- Drugmaker Agrees To Stop Selling Unapproved Skin Drugs
- Challenge To FTC Authority Belongs In Calif., Agency Says
- Greenberg Sued By 'Biggest Loser' Trainer Over Contracts
- FDA Guidance On Medical Device Reporting: Key Takeaways
- Making America Manufacture Drugs Again
- Finding Jurisdiction When Paragraph IV Shifts To Paragraph III
- New Business Opportunities In Shared Workspaces
- CORRECTED: Greenberg Traurig Settles Malpractice Suit As Trial Closes
- CEO's $46M IPO Windfall Not Fraud, Cancer Therapy Co. Says
- GSK Says Reed Smith Atty's Job Anxieties Led To Suicide
- Pfizer Wins TRO In Info Theft Suit Against Ex-Marketing Head
- 20 More States Join Generic Drug-Pricing Antitrust Action
- Theranos Says Investors Can't Sue Over Blood Tests
- Doctor Asks 11th Circ. To Rehear Enbrel Libel Case
- Fed. Circ. Affirms $455M Award To Bayer In Dow Patent Case
- Biosimilar Talks Needed To Trigger Litigation Clock: Judge
- Fed. Circ. Asked To Decide When Appeals Require Opinion
- Pa. Appeals Court OKs Attys' Fees Claim Above Damage Cap
- Long-Awaited IP Trial Between WL Gore, CR Bard Kicks Off
- 8th Circ. Affirms Dismissal Of Medtronic Derivative Suit
- Bayer Aims To Trim Debt In $1.58B Covestro Stake Sale
- Pfizer Prices €4B Bond To Repay Debt
- Genentech Biosimilar Suit Tossed After Just 2 Weeks
- Former ArthroCare Exec Wants 5th Circ.'s Decision Enforced
- Calif. County Can't Take Avandia Ad Claims To State Court
- PTAB Upholds Vimovo Patent Claims Challenged By Lupin
- A Survey Of Recent Life Sciences Securities Class Actions
- 2nd Requests Almost Always Spell Trouble For Deals
- FDA Oversight Of Lab-Developed Tests Is Likely To Lessen
- 2016 Patent Litigation: A Year In Review
- Patent Litigation 2016: A Law360 Special Report
- These Law Firms Dominated At The Federal Circuit In 2016
- Patent Litigation In US District Courts: A 2016 Review
- 4 Frequent Filers Of IP Suits To Watch This Year
- The Federal Circuit Judges You Want On Your PTAB Appeal
- Fed. Circ. Taking Harder Look At PTAB Appeals
- Inter Partes Reviews Becoming Friendlier To Patent Owners
- AIA Proceedings At The Patent Board: A Closer Look
- Law360's Federal Circuit Snapshot: By The Numbers
- Fed. Circ. Issuing More 'Hidden Decisions' Amid Case Influx
- ITC Patent Cases Rebound To Reach 5-Year High
- What The Intuitive Ruling Means For Medical Device Makers